River Therapeutics

Drug Discovery

Joint Venture between a drug discovery company and a billion-dollar Nasdaq listed U.S. biotech

Exclusive advisor

United Kingdom, June 2023

    • 2023, manufacturing
This website uses cookie files to provide you with the highest quality services. If you give consent to having information contained in cookie files recorded, choose OK. Otherwise please change the settings of your browser.
OK